Ascena Retail Group (ASNA) Pleased with Justice Comps; Cowen Reiterates Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Trump says Canada's Bombardier must build jets in US or lose market access
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- European shares subdued as surging crude sharpens focus on ECB rate path
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Ascena Retail Group (ASNA) Reports 1Q EPS Beat; Piper Jaffray Raises Price Target to $18
December 2, 2015 7:28 AM ESTPiper Jaffray reiterated an Overweight rating on Ascena Retail Group (NASDAQ: ASNA), and raised the price target to $18.00 (from $17.00), following the company's 1Q earnings report. EPS of $0.36 solidly bested expectations of $0.28 and management reiterated their guidance for the full year calling for EPS in the range of $0.75-$0.80. Management indicated on the conference... More
After-Hours Movers 12/01: (ONDK) (APIC) (ASNA) Higher; (OGXI) (POWL) (BOBE) Lower (more...)
December 1, 2015 5:54 PM ESTOncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) 32% LOWER; Following an independent Data Monitoring Committee (DMC) meeting, OncoGenex announced today that its Phase 3 AFFINITY trial is continuing based on the pre-planned interim futility analysis of the intent-to-treat (ITT) population. In the final safety review, no new safety issues were identified by the DMC. Both the DMC and OncoGenex remain blinded to all analyses and final results are expected in the second half of 2016, depending on timing of the event-driven final analysis. Separately, an analysis of a prospectively defined subpopulation of men... More
Ascena Retail Group (ASNA) Tops Q1 EPS by 7c, Maintains FY16 EPS Guidance
December 1, 2015 4:19 PM EST(Updated with guidance)
Ascena Retail Group (NASDAQ: ASNA) reported Q1 EPS of $0.36, $0.07 better than the analyst estimate of $0.29. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.78 billion. First quarter comparable sales were down 3%.
Fiscal 2016 Guidance
As a result... More
Trading Radar for 12/1: Scotiabank (BNS), Ascena Retail (ASNA), Ooma (OOMA), UTI (UTI) Report
November 30, 2015 2:57 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
BMO Financial Group (NYSE: BMO) - consensus EPS $1.74
Bank of Nova Scotia (NYSE: BNS) - consensus... More
